Article
Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours
21 Oct 2019
Abstract excerpt
BACKGROUND: Neuroblastoma (NB) is a paediatric tumour of the sympathetic nervous system. Half of all cases are defined high-risk with an overall survival less than 40% at 5 years from diagnosis. The lack of in vitro models able to recapitulate the intrinsic heterogeneity of primary NB tumours has hindered progress in understanding disease pathogenesis and therapy response. METHODS: Here we describe the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
